It was reported that a higher infiltration of tumor-associated neutrophils (TANs) expressing IL-8RB/CXCR2 upon neoadjuvant treatment with the vaccine GVAX and nivolumab was associated with poorer survival [35]. The gene discussed is CXCR2; the disease is neoplasm.